Accueil   Diary - News   All news Focus on Fluoptics

Focus on Fluoptics

Fluoptics, Lyonbiopole member’s, based in Grenoble, develops and markets innovative solutions in the field of fluorescence image-guided surgery. Early June, the company has obtained the Food and Drug Administration clearance for its clinical imaging system, Fluobeam®. In the meantime, Flupotics established a subsidiary in the United States, Fluoptics Imaging Inc. dedicated to the marketing of its innovative solutions.

 

Technology

The innovative solutions developed by Fluoptics combine optical imaging system in the near infrared and the use of injectable fluorescent tracers . They used to assist the surgeon in the operating room to help him see during the operation he can not discern with the naked eye . These solutions have many applications in the field of cancer surgery (removal of cancerous tumors , detection of the sentinel nodes ) but also cardiovascular surgery (Verification of blood flow ) , in reconstructive surgery ( vascularization verification shreds ) and in liver surgery (removal of tumors and metastases) .  

 

News

In early June, the company received certification from the Food and Drug Administration (FDA) for marketing in the US of its optical imaging system Fluobeam® . Read the Press Release At the same time , Fluoptics established a subsidiary in the United States , Fluoptics Imaging Inc. dedicated to the commercial distribution of innovative solutions .    

 

Contact
Odile Allard , CEO odile.allard@fluoptics.com
Tel .: +33 (0) 4 38 78 28 78 http://www.fluoptics.com

 

  

Fluoptics